AR080054A1 - Formulaciones antiparasitarias topicas - Google Patents
Formulaciones antiparasitarias topicasInfo
- Publication number
- AR080054A1 AR080054A1 ARP110100294A ARP110100294A AR080054A1 AR 080054 A1 AR080054 A1 AR 080054A1 AR P110100294 A ARP110100294 A AR P110100294A AR P110100294 A ARP110100294 A AR P110100294A AR 080054 A1 AR080054 A1 AR 080054A1
- Authority
- AR
- Argentina
- Prior art keywords
- formulation
- acid
- vitamin
- antioxidant
- butyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 5
- 238000009472 formulation Methods 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 4
- 239000003607 modifier Substances 0.000 abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid group Chemical group C(CCCCC(=O)O)(=O)O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 abstract 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 abstract 2
- 235000011187 glycerol Nutrition 0.000 abstract 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 abstract 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 abstract 2
- FXJRDUKXWHFPND-NSHDSACASA-N 2-[(1s)-1-(2,3-dimethylphenyl)ethyl]-1h-imidazole Chemical compound C1([C@@H](C)C=2C(=C(C)C=CC=2)C)=NC=CN1 FXJRDUKXWHFPND-NSHDSACASA-N 0.000 abstract 1
- CCTFMNIEFHGTDU-UHFFFAOYSA-N 3-methoxypropyl acetate Chemical compound COCCCOC(C)=O CCTFMNIEFHGTDU-UHFFFAOYSA-N 0.000 abstract 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 abstract 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 abstract 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000005899 Fipronil Substances 0.000 abstract 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 abstract 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 abstract 1
- 239000005639 Lauric acid Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000001361 adipic acid Substances 0.000 abstract 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 abstract 1
- 229950003960 demiditraz Drugs 0.000 abstract 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 abstract 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 abstract 1
- 229940013764 fipronil Drugs 0.000 abstract 1
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000001087 glyceryl triacetate Substances 0.000 abstract 1
- 235000013773 glyceryl triacetate Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- DOIRQSBPFJWKBE-UHFFFAOYSA-N phthalic acid di-n-butyl ester Natural products CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 abstract 1
- -1 propylgalate Chemical compound 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 235000010265 sodium sulphite Nutrition 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
- 229960002622 triacetin Drugs 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Formulaciones topicas que comprenden demiditraz, fipronil, un modificador ácido, al menos un vehículo veterinariamente aceptable y opcionalmente, al menos un antioxidante para tratar una infestacion o infeccion parasitaria en animales. Reivindicacion 2: La formulacion de la reivindicacion 1, en la que el modificador ácido es un ácido débil. Reivindicacion 3: La formulacion de la reivindicacion 2, en la que el modificador ácido es un derivado de ácido carboxílico. Reivindicacion 4: La formulacion de la reivindicacion 3, en la que el derivado de ácido carboxílico se selecciona de ácido adípico, cítrico y láurico. Reivindicacion 5: La formulacion de la reivindicacion 2, en la que el vehículo veterinariamente aceptable se selecciona de un alcohol, N-metil pirrolidinona, 2-pirrolidona, polivinilpirrolidinona, triacetina, gamma-hexalactona, glicerina, glicerol formal, acetato de metoxipropilo, agua y un éter de glicol, o una mezcla de los mismos. Reivindicacion 7: La formulacion de la reivindicacion 6, en la que el antioxidante se selecciona de vitamina C, vitamina E, propilgalato, 2-t-butil-4-metoxifenol, 2,6-di-t-butil-4-metilfenol, EDTA disodico, sulfito de sodio y palmitato de ascorbilo, o una mezcla de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29938410P | 2010-01-29 | 2010-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080054A1 true AR080054A1 (es) | 2012-03-07 |
Family
ID=44319916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110100294A AR080054A1 (es) | 2010-01-29 | 2011-01-28 | Formulaciones antiparasitarias topicas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120316210A1 (es) |
| EP (1) | EP2528444A2 (es) |
| JP (1) | JP2011157355A (es) |
| KR (1) | KR20120120376A (es) |
| CN (1) | CN102711480A (es) |
| AR (1) | AR080054A1 (es) |
| AU (1) | AU2011210267A1 (es) |
| BR (1) | BR112012017540A2 (es) |
| CA (1) | CA2784718A1 (es) |
| MX (1) | MX2012008799A (es) |
| WO (1) | WO2011092604A2 (es) |
| ZA (1) | ZA201206465B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012340351B2 (en) | 2011-11-17 | 2017-06-15 | Boehringer Ingelheim Animal Health USA Inc. | Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof |
| JO3626B1 (ar) * | 2012-02-23 | 2020-08-27 | Merial Inc | تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها |
| CN103688876A (zh) * | 2013-12-11 | 2014-04-02 | 常熟市创裕印染有限公司 | 多功能宠物服饰 |
| CN107811967B (zh) * | 2016-09-09 | 2021-08-24 | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | 抗寄生虫药物原位固化缓释注射剂及其制备方法 |
| GB201707930D0 (en) * | 2017-05-17 | 2017-06-28 | Syngenta Participations Ag | Formulation component |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426333B1 (en) | 1996-09-19 | 2002-07-30 | Merial | Spot-on formulations for combating parasites |
| FR2753377B1 (fr) | 1996-09-19 | 1999-09-24 | Rhone Merieux | Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides |
| GB8713768D0 (en) | 1987-06-12 | 1987-07-15 | May & Baker Ltd | Compositions of matter |
| GB8613914D0 (en) | 1986-06-07 | 1986-07-09 | Coopers Animal Health | Liquid formulations |
| FR2739255B1 (fr) | 1995-09-29 | 1998-09-04 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
| IE80657B1 (en) * | 1996-03-29 | 1998-11-04 | Merial Sas | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs |
| US7592362B2 (en) | 2006-01-19 | 2009-09-22 | Pfizer Limited | Substituted imidazoles |
| US20100041712A1 (en) * | 2008-08-18 | 2010-02-18 | Pfizer Inc. | Substituted imidazole combinations |
| BRPI1008403A2 (pt) * | 2009-02-23 | 2015-08-25 | Wyeth Llc | Formulação ectoparasiticida de odor melhorado |
-
2011
- 2011-01-04 AU AU2011210267A patent/AU2011210267A1/en not_active Abandoned
- 2011-01-04 EP EP11702506A patent/EP2528444A2/en not_active Withdrawn
- 2011-01-04 CA CA2784718A patent/CA2784718A1/en not_active Abandoned
- 2011-01-04 CN CN2011800061480A patent/CN102711480A/zh active Pending
- 2011-01-04 BR BR112012017540A patent/BR112012017540A2/pt not_active IP Right Cessation
- 2011-01-04 MX MX2012008799A patent/MX2012008799A/es not_active Application Discontinuation
- 2011-01-04 US US13/522,339 patent/US20120316210A1/en not_active Abandoned
- 2011-01-04 WO PCT/IB2011/050027 patent/WO2011092604A2/en not_active Ceased
- 2011-01-04 KR KR1020127022437A patent/KR20120120376A/ko not_active Ceased
- 2011-01-26 JP JP2011013786A patent/JP2011157355A/ja active Pending
- 2011-01-28 AR ARP110100294A patent/AR080054A1/es not_active Application Discontinuation
-
2012
- 2012-08-28 ZA ZA2012/06465A patent/ZA201206465B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011210267A1 (en) | 2012-09-20 |
| EP2528444A2 (en) | 2012-12-05 |
| JP2011157355A (ja) | 2011-08-18 |
| WO2011092604A3 (en) | 2012-03-01 |
| WO2011092604A2 (en) | 2011-08-04 |
| MX2012008799A (es) | 2012-08-23 |
| KR20120120376A (ko) | 2012-11-01 |
| CN102711480A (zh) | 2012-10-03 |
| US20120316210A1 (en) | 2012-12-13 |
| ZA201206465B (en) | 2014-02-26 |
| CA2784718A1 (en) | 2011-08-04 |
| BR112012017540A2 (pt) | 2016-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6220926A2 (es) | Formulacion farmaceutica topica para la aplicacion de un farmaco antiinflamatorio no esferoidal (nsaid) | |
| CA2864118A1 (en) | Formulations of bendamustine | |
| CY1122838T1 (el) | Τοπικες συνθεσεις οι οποιες περιλαμβανουν φιπρονιλη και περμεθρινη και μεθοδοι χρησης | |
| MX2020001395A (es) | Composiciones y su uso para suministro de iduronato-2-sulfatasa al sistema nervioso central. | |
| AR080054A1 (es) | Formulaciones antiparasitarias topicas | |
| BR112012030653A2 (pt) | composição tópica em aerosol, estável ao armazenamento e substancialmente anidra, e, recipiente pressurizado | |
| AR097791A1 (es) | Formulaciones de anticuerpos anti-pdl1 | |
| NZ596657A (en) | Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof | |
| DOP2012000011A (es) | Formulacion farmaceutica | |
| WO2009139589A3 (en) | Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant | |
| GT200900192A (es) | Derivados de imidazol como inhibidores de proteina de uso de cinesina (eg-5).- | |
| AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
| CL2011001225A1 (es) | Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros. | |
| BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
| BR112015018270A2 (pt) | composições que compreendem 15-ohepa e métodos de uso das mesmas | |
| MX2009012782A (es) | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. | |
| BR112014001829A2 (pt) | composições tópicas antioxidantes | |
| NZ601001A (en) | Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue | |
| WO2014178789A9 (en) | Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients | |
| EA201490363A1 (ru) | Новые составы на основе (триметоксифениламино)пиримидинилов | |
| MX363417B (es) | Composicion vaginal a base de poliglucosidos de alquilo. | |
| PE20131137A1 (es) | Composiciones nasales de vitamina b12 | |
| EA201270745A1 (ru) | Улучшенный стабильный водный состав (e)-4-карбоксистирил-4-хлорбензилсульфона | |
| PE20130180A1 (es) | Soluciones farmaceuticas orales que comprenden telbivudina | |
| NZ591529A (en) | Chemical composition for skin care formulations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |